Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.

Bibliographic Details
Main Authors:	Delmas, P, Rizzoli, R, Cooper, C, Reginster, J
Format:	Journal article
Language:	English
Published:	2005

Similar Items

The International Osteoporosis Foundation: History, objectives and achievements
by: Cooper, C, et al.
Published: (2009)

The International Osteoporosis Foundation: history, objectives and achievements.
by: Cooper, C, et al.
Published: (2009)

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).
by: Cooper, C, et al.
Published: (2012)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (Osteoporosis International DOI: 10.1007/s00198-008-0560-z)
by: Kanis, J, et al.
Published: (2008)

Is screening for osteoporosis worthwhile?
by: Walker-Bone, K, et al.
Published: (1998)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
by: Kanis, J, et al.
Published: (2008)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
by: Kanis, J, et al.
Published: (2013)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (vol 19, pg 399, 2008)
by: Kanis, J, et al.
Published: (2008)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
by: Rizzoli, R, et al.
Published: (2011)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
by: Rizzoli, R, et al.
Published: (2011)

Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.
by: Kanis, J, et al.
Published: (1997)

Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.
by: Rizzoli, R, et al.
Published: (2011)

International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis.
by: Vasikaran, S, et al.
Published: (2011)

Pathogenesis and treatment of postmenopausal osteoporosis
by: Milhaud, G, et al.
Published: (1983)

Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for Osteoporosis.
by: Lips, P, et al.
Published: (1997)

Thai Osteoporosis Foundation (TOPF) position statements on management of osteoporosis
by: T. Songpatanasilp, et al.
Published: (2016-12-01)

Treatment of osteoporosis in men.
by: Kaufman, J, et al.
Published: (2013)

Treatment options for postmenopausal osteoporosis
by: Walsh GM
Published: (2012-08-01)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
by: Pazianas, M, et al.
Published: (2010)

Assessment and Treatment of Postmenopausal Osteoporosis: An Appraisal of International Guidelines
by: Sumapa Chaiamnuay
Published: (2022-06-01)

Long-Term Treatment of Postmenopausal Osteoporosis
by: Jacques P. Brown
Published: (2021-06-01)

A reappraisal of generic bisphosphonates in osteoporosis.
by: Kanis, J, et al.
Published: (2012)

Long treatment with strontium ranelate of womenwith postmenopausal osteoporosis: 10-year results
by: J Y Reginster, et al.
Published: (2011-04-01)

BREASTFEEDING AND POSTMENOPAUSAL OSTEOPOROSIS
by: Horia Lăzărescu, et al.
Published: (2019-09-01)

Botanicals in Postmenopausal Osteoporosis
by: Wojciech Słupski, et al.
Published: (2021-05-01)

Hypercalciuria in Postmenopausal Osteoporosis
by: Ayfer Kanberoğlu, et al.
Published: (2004-06-01)

Osteoporosis in postmenopausal women
by: Harvey, M, et al.
Published: (2002)

Management of postmenopausal osteoporosis
by: Yeap SS, et al.
Published: (2013-10-01)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
by: Michael Pazianas, et al.
Published: (2010-07-01)

Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
by: E&nbsp;Michael Lewiecki
Published: (2009-10-01)

Efficacy and safety of oral weekly ibandronate in the treatment of postmenopausal osteoporosis.
by: Cooper, C, et al.
Published: (2003)

Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.
by: Miller, P, et al.
Published: (2005)

Partial adherence: a new perspective on health economic assessment in osteoporosis.
by: Kanis, J, et al.
Published: (2011)

Antidepressant medications and osteoporosis
by: Rizzoli, R, et al.
Published: (2012)

Postmenopausal osteoporosis: Our experience
by: R N Mehrotra, et al.
Published: (2012-01-01)

Indications to teriparatide treatment in patients with osteoporosis
by: R Rizzoli, et al.
Published: (2011-11-01)

Brazilian guidelines for the diagnosis and treatment of postmenopausal osteoporosis
by: Sebastião Cézar Radominski, et al.

Application of Osteorisk to postmenopausal patients with osteoporosis
by: Marcelo Luis Steiner, et al.

Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women.
by: Lundkvist, J, et al.
Published: (2006)

The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF).
by: Harvey, N, et al.
Published: (2016)